Evaluation of predictive biomarkers and the host immune response to intrapleural administration of oncolytic Measles virus in a phase I clinical trial specifically for patients with mesothelioma
|Effective start/end date||1/1/11 → 12/31/13|
- MESOTHELIOMA APPLIED RESEARCH FOUNDATION
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.